<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To assess toxicity of <z:chebi fb="0" ids="7959">D-penicillamine</z:chebi> a retrospective chart review was performed on 63 patients with <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> receiving <z:chebi fb="0" ids="50868,7959">penicillamine</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>These patients had a total of 83 courses of therapy </plain></SENT>
<SENT sid="2" pm="."><plain>The mean age of patients was 52 years and the mean duration of disease was 10.07 years </plain></SENT>
<SENT sid="3" pm="."><plain>Laboratory data showed an increase in hematocrit values from 36 per cent to 40 per cent and a decrease in the erythrocyte sedimentation rate from an average of 50 to 29 mm/hour </plain></SENT>
<SENT sid="4" pm="."><plain>The platelet count also decreased with treatment from 394,000 to 267,000/mm3 </plain></SENT>
<SENT sid="5" pm="."><plain>The over-<z:hpo ids='HP_0000001'>all</z:hpo> complication rate was 53 per cent </plain></SENT>
<SENT sid="6" pm="."><plain>Life-threatening complications occurred in two patients including one case of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and one case of <z:hpo ids='HP_0000100'>nephrotic syndrome</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>One additional patient was referred with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Minor complications include <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e> in 18 per cent, loss of taste in 6 per cent, <z:e sem="disease" ids="C0013395" disease_type="Disease or Syndrome" abbrv="">dyspepsia</z:e> in 11 per cent, <z:e sem="disease" ids="C0149745" disease_type="Disease or Syndrome" abbrv="">oral ulceration</z:e> in 7 per cent and <z:hpo ids='HP_0000093'>proteinuria</z:hpo> of less than 3 g/day in 8 per cent </plain></SENT>
<SENT sid="9" pm="."><plain>In summary, 53 per cent of the courses of <z:chebi fb="0" ids="50868,7959">penicillamine</z:chebi> were associated with toxicity including one episode of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and one case of <z:hpo ids='HP_0000100'>nephrotic syndrome</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Therapy was stopped due to complications in 39 per cent of the patients in this series </plain></SENT>
</text></document>